Joseph A M J L Janssen (J A M J L Janssen)

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Topics

Monoclonal Antibody

Top Venues

International journal of molecular sciences

Clinical endocrinology

The Journal of clinical endocrinology and metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Joseph A M J L Janssen
Overnutrition, Hyperinsulinemia and Ectopic Fat: It Is Time for A Paradigm Shift in the Management of Type 2 Diabetes. International journal of molecular sciences 25 (10) (2024)
Joseph A M J L Janssen
Overnutrition, Hyperinsulinemia and Ectopic Fat: It Is Time for A Paradigm Shift in the Management of Type 2 Diabetes. International journal of molecular sciences 25 (10) (2024)
Joseph A M J L Janssen
Overnutrition, Hyperinsulinemia and Ectopic Fat: It Is Time for A Paradigm Shift in the Management of Type 2 Diabetes. International journal of molecular sciences 25 (10) (2024)
Joseph A M J L Janssen
The Impact of Westernization on the Insulin/IGF-I Signaling Pathway and the Metabolic Syndrome: It Is Time for Change. International journal of molecular sciences 24 (5) (2023)
Joseph A M J L Janssen
The Impact of Westernization on the Insulin/IGF-I Signaling Pathway and the Metabolic Syndrome: It Is Time for Change. International journal of molecular sciences 24 (5) (2023)
Joseph A M J L Janssen
The Impact of Westernization on the Insulin/IGF-I Signaling Pathway and the Metabolic Syndrome: It Is Time for Change. International journal of molecular sciences 24 (5) (2023)
Joseph A M J L Janssen
New Insights into the Role of Insulin and Hypothalamic-Pituitary-Adrenal (HPA) Axis in the Metabolic Syndrome. International journal of molecular sciences 23 (15) (2022)
Leonard Girnita, Terry J Smith, Joseph A M J L Janssen
It Takes Two to Tango: IGF-I and TSH Receptors in Thyroid Eye Disease. The Journal of clinical endocrinology and metabolism 107 (Suppl_1) (2022)
Joseph A M J L Janssen
Hyperinsulinemia and Its Pivotal Role in Aging, Obesity, Type 2 Diabetes, Cardiovascular Disease and Cancer. International journal of molecular sciences 22 (15) (2021)
Joseph A M J L Janssen, Terry J Smith
Lessons Learned from Targeting IGF-I Receptor in Thyroid-Associated Ophthalmopathy. Cells 10 (2) (2021)
Joseph A M J L Janssen
New Insights from IGF-IR Stimulating Activity Analyses: Pathological Considerations. Cells 9 (4) (2020)
A J Varewijck, A J van der Lely, S J C M M Neggers, L J Hofland, Joseph A M J L Janssen
Disagreement in normative IGF-I levels may lead to different clinical interpretations and GH dose adjustments in GH deficiency. Clinical endocrinology 88 (3) (2017)